InnoModels Biotechnology (Beijing) Co., Ltd_PDX_CDX_FACS

Cn / En

InnoModels

Provide top-quality preclinical services to pharmaceutical enterprises and translational research institutions

InnoModels

Have an experienced and high-performing management and research team

InnoModels

Focus on the development and application of oncology and Immun-oncology models

InnoModels

Combine innovative preclinical technology and unrivaled expertise to enable more efficient drug discovery and development





Tel 15010000264
E-mail limy@imodels.tech
Tel 13810723384
Top

R&D Service Platform

Humanized mice for l/O

iHuPBMC-T ， iHuPBMC-NK，iHuPBMC-B， iHuPBMC-Donor screening and QC, iHuPBMC-OncVax medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models.

Oncology in vivo

CDX models，iHuPDX models，

Orthotopic models，

Orthotopic mouse brain models...

in vitro cytotoxicity test

Patient-derived tumor cell screening, 3D orgnoid, IC50, Immunue cells mediated tumor killing assays immunotherapy to provide close to the clinical trials of a new generation of animal models.

Syngeneic models for l/O

Syngeneic models,

NK function assay in SCID mice, Genetically engineered mouse models

Cancer vaccine evaluation

Syngeneic-OncVax for cancer vaccine, MHC humanized mouse

Cell therapy

Car-T,Car-NK,

Car-T in MHC/KO mice,

Host vs graft (HVG)

in vitro immune assay

ELISpot,

ELISA,

FACS, qPCR

Non-GLP tox

GVHD experimental platform，

Immunogenicity Testing

PDX model

Lymphoma (LY),Chronic myeloproliferitve neoplasm (CMP), Myelodisplasic syndrome (MDS)

CDX model

Eosinophilia (EOS), Leukemia (LK), Myeloma (MYMA), Mastocytosis (MAS), Musculoskeletal and vascular systems (MSKV)

Syngeneic model

Nervous system (NS),Urinary system (US),Endocrine System (ES),

Female reproductory system (FRS)...

Database

【Database 1】

【Database 2】

InnoModels News

InnoModels has a stable immune system humanized mouse model platform (HIS) and a human tumor allotransplantation platform (PDX) in China.

News and Events

InnoModels always adhere to the quality of development, quality of survival principle, to promote the company to the development of collectivized economy

Company News

InnoModels Biotechnology: Exploring the Innovative Path of Humanized Models of the Immune System

17 01

News and Events

InnoModels Biotechnology: Exploring the Innovative Path of Humanized Models of the Immune System

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients

27 11

News and Events

Overview of iHuPBMC-T Technology from InnoModels Biotechnology

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.

25 11

News and Events

Introducing the Patent of PBMC Immune System Reconstruction Capability Detection Method and Application by InnoModels Biotechnology

Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models

18 10

News and Events

InnoModels Biotechnology ELISpot platform: a powerful tool to precisely analyze the immune response

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality





MORE

About InnoModels

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models. Gen die creature has domestic stability of the humanized mice immune system model (ihs) platform, and anthropogenic tumor allografts platform (symbol), focusing on tumor and tumor immune pharmacodynamics CRO services, translational medicine research service, individualized medicine, service transformation of new drug research and development enterprise, medical researchers, cancer patients, is dedicated to the research and development of tumor and tumor immunotherapy to provide close to the clinical trials of a new generation of animal models.

MORE

InnoModels Biotechnology (Beijing) Co., Ltd

TEL：15010000264 13810723384

Email：cndw@imodels.tech

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company